The primary criteria for the diagnosis of Major Depressive Disorder in DSM-4:
Major Depressive Disorder requires two or more major depressive episodes.
Diagnostic criteria:
Depressed mood and/or loss of interest or pleasure in life activities for at least 2 weeks and at least five of the following symptoms that cause clinically significant impairment in social, work, or other important areas of functioning almost every day
1. Depressed mood most of the day.
2. Diminished interest or pleasure in all or most activities.
3. Significant unintentional weight loss or gain.
4. Insomnia or sleeping too much.
5. Agitation or psychomotor retardation noticed by others.
6. Fatigue or loss of energy.
7. Feelings of worthlessness or excessive guilt.
8. Diminished ability to think or concentrate, or indecisiveness.
9. Recurrent thoughts of death
(www.ncbi.nlm.nih.gov)
Overview
Depression (major depressive disorder or clinical depression) is a common but serious mood disorder. It causes severe symptoms that affect how you feel, think, and handle daily activities, such as sleeping, eating, or working. To be diagnosed with depression, the symptoms must be present for at least two weeks.
Some forms of depression are slightly different, or they may develop under unique circumstances, such as:
• Persistent depressive disorder (also called dysthymia) is a depressed mood that lasts for at least two years. A person diagnosed with persistent depressive disorder may have episodes of major depression along with periods of less severe symptoms, but symptoms must last for two years to be considered persistent depressive disorder.
• Postpartum depression is much more serious than the “baby blues” (relatively mild depressive and anxiety symptoms that typically clear within two weeks after delivery) that many women experience after giving birth. Women with postpartum depression experience full-blown major depression during pregnancy or after delivery (postpartum depression). The feelings of extreme sadness, anxiety, and exhaustion that accompany postpartum depression may make it difficult for these new mothers to complete daily care activities for themselves and/or for their babies.
• Psychotic depression occurs when a person has severe depression plus some form of psychosis, such as having disturbing false fixed beliefs (delusions) or hearing or seeing upsetting things that others cannot hear or see (hallucinations). The psychotic symptoms typically have a depressive “theme,” such as delusions of guilt, poverty, or illness.
• Seasonal affective disorder is characterized by the onset of depression during the winter months, when there is less natural sunlight. This depression generally lifts during spring and summer. Winter depression, typically accompanied by social withdrawal, increased sleep, and weight gain, predictably returns every year in seasonal affective disorder.
• Bipolar disorder is different from depression, but it is included in this list is because someone with bipolar disorder experiences episodes of extremely low moods that meet the criteria for major depression (called “bipolar depression”). But a person with bipolar disorder also experiences extreme high – euphoric or irritable – moods called “mania” or a less severe form called “hypomania.”
Examples of other types of depressive disorders newly added to the diagnostic classification of DSM-5 include disruptive mood dysregulation disorder (diagnosed in children and adolescents) and premenstrual dysphoric disorder (PMDD).
Risk Factors
Depression is one of the most common mental disorders in the U.S. Current research suggests that depression is caused by a combination of genetic, biological, environmental, and psychological factors.
Depression can happen at any age, but often begins in adulthood. Depression is now recognized as occurring in children and adolescents, although it sometimes presents with more prominent irritability than low mood. Many chronic mood and anxiety disorders in adults begin as high levels of anxiety in children.
Depression, especially in midlife or older adults, can co-occur with other serious medical illnesses, such as diabetes, cancer, heart disease, and Parkinson’s disease. These conditions are often worse when depression is present. Sometimes medications taken for these physical illnesses may cause side effects that contribute to depression. A doctor experienced in treating these complicated illnesses can help work out the best treatment strategy.
Risk factors include:
• Personal or family history of depression
• Major life changes, trauma, or stress
• Certain physical illnesses and medications
Depression: Introduction
Do you feel sad, empty, and hopeless most of the day, nearly every day? Have you lost interest or pleasure in your hobbies or being with friends and family? Are you having trouble sleeping, eating, and functioning? If you have felt this way for at least 2 weeks, you may have depression, a serious but treatable mood disorder.
What is depression?
Everyone feels sad or low sometimes, but these feelings usually pass with a little time. Depression—also called “clinical depression” or a “depressive disorder”—is a mood disorder that causes distressing symptoms that affect how you feel, think, and handle daily activities, such as sleeping, eating, or working. To be diagnosed with depression, symptoms must be present most of the day, nearly every day for at least 2 weeks.
What are the different types of depression?
Two of the most common forms of depression are:
• Major depression — having symptoms of depression most of the day, nearly every day for at least 2 weeks that interfere with your ability to work, sleep, study, eat, and enjoy life. An episode can occur only once in a person’s lifetime, but more often, a person has several episodes.
• Persistent depressive disorder (dysthymia)—having symptoms of depression that last for at least 2 years. A person diagnosed with this form of depression may have episodes of major depression along with periods of less severe symptoms.
Some forms of depression are slightly different, or they may develop under unique circumstances, such as:
• Perinatal Depression: Women with perinatal depression experience full-blown major depression during pregnancy or after delivery (postpartum depression).
• Seasonal Affective Disorder (SAD): SAD is a type of depression that comes and goes with the seasons, typically starting in the late fall and early winter and going away during the spring and summer.
• Psychotic Depression: This type of depression occurs when a person has severe depression plus some form of psychosis, such as having disturbing false fixed beliefs (delusions) or hearing or seeing upsetting things that others cannot hear or see (hallucinations).
Other examples of depressive disorders include disruptive mood dysregulation disorder (diagnosed in children and adolescents) and premenstrual dysphoric disorder. Depression can also be one phase of bipolar disorder (formerly called manic-depression). But a person with bipolar disorder also experiences extreme high—euphoric or irritable —moods called “mania” or a less severe form called “hypomania.”
What causes depression?
Scientists at NIMH and across the country are studying the causes of depression. Research suggests that a combination of genetic, biological, environmental, and psychological factors play a role in depression.
Depression can occur along with other serious illnesses, such as diabetes, cancer, heart disease, and Parkinson’s disease. Depression can make these conditions worse and vice versa. Sometimes medications taken for these illnesses may cause side effects that contribute to depression symptoms.
Signs and Symptoms
If you have been experiencing some of the following signs and symptoms most of the day, nearly every day, for at least two weeks, you may be suffering from depression:
• Persistent sad, anxious, or “empty” mood
• Feelings of hopelessness, or pessimism
• Irritability
• Feelings of guilt, worthlessness, or helplessness
• Loss of interest or pleasure in hobbies and activities
• Decreased energy or fatigue
• Moving or talking more slowly
• Feeling restless or having trouble sitting still
• Difficulty concentrating, remembering, or making decisions
• Difficulty sleeping, early-morning awakening, or oversleeping
• Appetite and/or weight changes
• Thoughts of death or suicide, or suicide attempts
• Aches or pains, headaches, cramps, or digestive problems without a clear physical cause and/or that do not ease even with treatment
Not everyone who is depressed experiences every symptom. Some people experience only a few symptoms while others may experience many. Several persistent symptoms in addition to low mood are required for a diagnosis of major depression, but people with only a few – but distressing – symptoms may benefit from treatment of their “subsyndromal” depression. The severity and frequency of symptoms and how long they last will vary depending on the individual and his or her particular illness. Symptoms may also vary depending on the stage of the illness.
What are the signs and symptoms of depression?
Sadness is only one small part of depression and some people with depression may not feel sadness at all. Different people have different symptoms. Some symptoms of depression include:
• Persistent sad, anxious, or “empty” mood
• Feelings of hopelessness or pessimism
• Feelings of guilt, worthlessness, or helplessness
• Loss of interest or pleasure in hobbies or activities
• Decreased energy, fatigue, or being “slowed down”
• Difficulty concentrating, remembering, or making decisions
• Difficulty sleeping, early-morning awakening, or oversleeping
• Appetite and/or weight changes
• Thoughts of death or suicide or suicide attempts
• Restlessness or irritability
• Aches or pains, headaches, cramps, or digestive problems without a clear physical cause and/or that do not ease even with treatment
Does depression look the same in everyone?
No. Depression affects different people in different ways. For example:
Women have depression more often than men. Biological, lifecycle, and hormonal factors that are unique to women may be linked to their higher depression rate. Women with depression typically have symptoms of sadness, worthlessness, and guilt.
Men with depression are more likely to be very tired, irritable, and sometimes angry. They may lose interest in work or activities they once enjoyed, have sleep problems, and behave recklessly, including the misuse of drugs or alcohol. Many men do not recognize their depression and fail to seek help.
Older adults with depression may have less obvious symptoms, or they may be less likely to admit to feelings of sadness or grief. They are also more likely to have medical conditions, such as heart disease, which may cause or contribute to depression.
Younger children with depression may pretend to be sick, refuse to go to school, cling to a parent, or worry that a parent may die.
Older children and teens with depression may get into trouble at school, sulk, and be irritable. Teens with depression may have symptoms of other disorders, such as anxiety, eating disorders, or substance abuse.
Treatment and Therapies
Depression, even the most severe cases, can be treated. The earlier that treatment can begin, the more effective it is. Depression is usually treated with medications, psychotherapy, or a combination of the two. If these treatments do not reduce symptoms, electroconvulsive therapy (ECT) and other brain stimulation therapies may be options to explore.
Quick Tip: No two people are affected the same way by depression and there is no "one-size-fits-all" for treatment. It may take some trial and error to find the treatment that works best for you.
Medications
Antidepressants are medicines that treat depression. They may help improve the way your brain uses certain chemicals that control mood or stress. You may need to try several different antidepressant medicines before finding the one that improves your symptoms and has manageable side effects. A medication that has helped you or a close family member in the past will often be considered.
Antidepressants take time – usually 2 to 4 weeks – to work, and often, symptoms such as sleep, appetite, and concentration problems improve before mood lifts, so it is important to give medication a chance before reaching a conclusion about its effectiveness. If you begin taking antidepressants, do not stop taking them without the help of a doctor. Sometimes people taking antidepressants feel better and then stop taking the medication on their own, and the depression returns. When you and your doctor have decided it is time to stop the medication, usually after a course of 6 to 12 months, the doctor will help you slowly and safely decrease your dose. Stopping them abruptly can cause withdrawal symptoms.
Please Note: In some cases, children, teenagers, and young adults under 25 may experience an increase in suicidal thoughts or behavior when taking antidepressants, especially in the first few weeks after starting or when the dose is changed. This warning from the U.S. Food and Drug Administration (FDA) also says that patients of all ages taking antidepressants should be watched closely, especially during the first few weeks of treatment.
If you are considering taking an antidepressant and you are pregnant, planning to become pregnant, or breastfeeding, talk to your doctor about any increased health risks to you or your unborn or nursing child.
To find the latest information about antidepressants, talk to your doctor and visit www.fda.gov.
You may have heard about an herbal medicine called St. John's wort. Although it is a top-selling botanical product, the FDA has not approved its use as an over-the-counter or prescription medicine for depression, and there are serious concerns about its safety (it should never be combined with a prescription antidepressant) and effectiveness. Do not use St. John’s wort before talking to your health care provider. Other natural products sold as dietary supplements, including omega-3 fatty acids and S-adenosylmethionine (SAMe), remain under study but have not yet been proven safe and effective for routine use. For more information on herbal and other complementary approaches and current research, please visit the National Center for Complementary and Integrative Health website.
Psychotherapies
Several types of psychotherapy (also called “talk therapy” or, in a less specific form, counseling) can help people with depression. Examples of evidence-based approaches specific to the treatment of depression include cognitive-behavioral therapy (CBT), interpersonal therapy (IPT), and problem-solving therapy. More information on psychotherapy is available on the NIMH website and in the NIMH publication Depression: What You Need to Know.
Brain Stimulation Therapies
If medications do not reduce the symptoms of depression, electroconvulsive therapy (ECT) may be an option to explore. Based on the latest research:
• ECT can provide relief for people with severe depression who have not been able to feel better with other treatments.
• Electroconvulsive therapy can be an effective treatment for depression. In some severe cases where a rapid response is necessary or medications cannot be used safely, ECT can even be a first-line intervention.
• Once strictly an inpatient procedure, today ECT is often performed on an outpatient basis. The treatment consists of a series of sessions, typically three times a week, for two to four weeks.
• ECT may cause some side effects, including confusion, disorientation, and memory loss. Usually these side effects are short-term, but sometimes memory problems can linger, especially for the months around the time of the treatment course. Advances in ECT devices and methods have made modern ECT safe and effective for the vast majority of patients. Talk to your doctor and make sure you understand the potential benefits and risks of the treatment before giving your informed consent to undergoing ECT.
• ECT is not painful, and you cannot feel the electrical impulses. Before ECT begins, a patient is put under brief anesthesia and given a muscle relaxant. Within one hour after the treatment session, which takes only a few minutes, the patient is awake and alert.
Other more recently introduced types of brain stimulation therapies used to treat medicine-resistant depression include repetitive transcranial magnetic stimulation (rTMS) and vagus nerve stimulation (VNS). Other types of brain stimulation treatments are under study. You can learn more about these therapies on the NIMH Brain Stimulation Therapies webpage.
If you think you may have depression, start by making an appointment to see your doctor or health care provider. This could be your primary care practitioner or a health provider who specializes in diagnosing and treating mental health conditions. Visit the NIMH Find Help for Mental Illnesses if you are unsure of where to start.
Beyond Treatment: Things You Can Do
Here are other tips that may help you or a loved one during treatment for depression:
• Try to be active and exercise.
• Set realistic goals for yourself.
• Try to spend time with other people and confide in a trusted friend or relative.
• Try not to isolate yourself, and let others help you.
• Expect your mood to improve gradually, not immediately.
• Postpone important decisions, such as getting married or divorced, or changing jobs until you feel better. Discuss decisions with others who know you well and have a more objective view of your situation.
• Continue to educate yourself about depression.
How is depression treated?
The first step in getting the right treatment is to visit a health care provider or mental health professional, such as a psychiatrist or psychologist. Your health care provider can do an exam, interview, and lab tests to rule out other health conditions that may have the same symptoms as depression. Once diagnosed, depression can be treated with medications, psychotherapy, or a combination of the two. If these treatments do not reduce symptoms, brain stimulation therapy may be another treatment option to explore.
Medications
Medications called antidepressants can work well to treat depression. They can take 2 to 4 weeks to work. Antidepressants can have side effects, but many side effects may lessen over time. Talk to your health care provider about any side effects that you have. Do not stop taking your antidepressant without first talking to your health care provider.
Please Note: Although antidepressants can be effective for many people, they may present serious risks to some, especially children, teens, and young adults. Antidepressants may cause some people, especially those who become agitated when they first start taking the medication and before it begins to work, to have suicidal thoughts or make suicide attempts. Anyone taking antidepressants should be monitored closely, especially when they first start taking them. For most people, though, the risks of untreated depression far outweigh those of antidepressant medications when they are used under a doctor’s careful supervision.
Information about medications changes frequently. Visit the U.S. Food and Drug Administration (FDA) website for the latest warnings, patient medication guides, or newly approved medications.
Psychotherapy
Psychotherapy helps by teaching new ways of thinking and behaving, and changing habits that may be contributing to depression. Therapy can help you understand and work through difficult relationships or situations that may be causing your depression or making it worse.
Brain Stimulation Therapies
Electroconvulsive therapy (ECT) and other brain stimulation therapies may be an option for people with severe depression who do not respond to antidepressant medications. ECT is the best studied brain stimulation therapy and has the longest history of use. Other stimulation therapies discussed here are newer, and in some cases still experimental methods.
How can I help myself if I am depressed?
As you continue treatment, you may start to feel better gradually. Remember that if you are taking an antidepressant, it may take 2 to 4 weeks to start working. Try to do things that you used to enjoy. Go easy on yourself. Other things that may help include:
• Trying to be active and exercise
• Breaking up large tasks into small ones, set priorities, and do what you can as you can
• Spending time with other people and confide in a trusted friend or relative
• Postponing important life decisions until you feel better. Discuss decisions with others who know you well
• Avoiding self-medication with alcohol or with drugs not prescribed for you
How can I help a loved one who is depressed?
If you know someone who has depression, first help him or her see a health care provider or mental health professional. You can also:
• Offer support, understanding, patience, and encouragement
• Never ignore comments about suicide, and report them to your loved one’s health care provider or therapist
• Invite him or her out for walks, outings, and other activities
• Help him or her adhere to the treatment plan, such as setting reminders to take prescribed medications
• Help him or her by ensuring that he or she has transportation to therapy appointments
• Remind him or her that, with time and treatment, the depression will lift
Where can I go for help?
If you are unsure where to go for help, ask your health provider or check out the NIMH Help for Mental Illnesses webpage at www.nimh.nih.gov/findhelp. Another Federal health agency, the Substance Abuse and Mental Health Services Administration (SAMHSA), maintains an online Behavioral Health Treatment Services Locator at https://findtreatment.samhsa.gov/. You can also check online for mental health professionals; contact your community health center, local mental health association, or insurance plan to find a mental health professional. Hospital doctors can help in an emergency.
If you or someone you know is in crisis, get help quickly.
• Call your or your loved one’s health professional.
• Call 911 for emergency services.
• Go to the nearest hospital emergency room.
• Call the toll-free, 24-hour hotline of the National Suicide Prevention Lifeline at 1-800-273-TALK (1-800-273-8255); TYY: 1-800-799-4TTY (4889).
Medications
Antidepressants are medicines that treat depression. They may help improve the way your brain uses certain chemicals that control mood or stress.
There are several types of antidepressants:
• Selective serotonin reuptake inhibitors (SSRI)
• Serotonin and norepinephrine reuptake inhibitors (SNRI)
• Tricyclic antidepressants (TCA)
• Monoamine oxidase inhibitors (MAOI)
There are other antidepressants that don’t fall into any of these categories and are considered unique, such as Mirtazapine and Bupropion.
Although all antidepressants can cause side effects, some are more likely to cause certain side effects than others. You may need to try several different antidepressant medicines before finding the one that improves your symptoms and has side effects that you can manage.
Most antidepressants are generally safe, but the U.S. Food and Drug Administration (FDA) requires that all antidepressants carry black box warnings, the strictest warnings for prescriptions. In some cases, children, teenagers, and young adults under age 25 may experience an increase in suicidal thoughts or behavior when taking antidepressants, especially in the first few weeks after starting or when the dose is changed. The warning also says that patients of all ages taking antidepressants should be watched closely, especially during the first few weeks of treatment.
Common side effects listed by the FDA for antidepressants are:
• Nausea and vomiting
• Weight gain
• Diarrhea
• Sleepiness
• Sexual problems
Other more serious but much less common side effects listed by the FDA for antidepressant medicines can include seizures, heart problems, and an imbalance of salt in your blood, liver damage, suicidal thoughts, or serotonin syndrome (a life-threatening reaction where your body makes too much serotonin). Serotonin syndrome can cause shivering, diarrhea, fever, seizures, and stiff or rigid muscles.
Your doctor may have you see a talk therapist in addition to taking medicine. Ask your doctor about the benefits and risks of adding talk therapy to your treatment. Sometimes talk therapy alone may be the best treatment for you.
If you are having suicidal thoughts or other serious side effects like seizures or heart problems while taking antidepressant medicines, contact your doctor immediately.
The National Suicide Prevention Lifeline is available at 1-800-273-TALK (8255), or you can visit www.suicidepreventionlifeline.org.
Medication
Antidepressants primarily work on brain chemicals called
neurotransmitters, especially serotonin and norepinephrine.
Other antidepressants work on the neurotransmitter dopamine.
Scientists have found that these particular chemicals
are involved in regulating mood, but they are unsure of the
exact ways that they work. Te latest information on medications
for treating depression is available on the U.S. Food and
Drug Administration (FDA) website at http://www.fda.gov.
Popular newer antidepressants
Some of the newest and most popular antidepressants are
called selective serotonin reuptake inhibitors (SSRIs). Fluoxetine
(Prozac), sertraline (Zoloſt), escitalopram (Lexapro),
paroxetine (Paxil), and citalopram (Celexa) are some of the
most commonly prescribed SSRIs for depression. Most are
available in generic versions. Serotonin and norepinephrine
reuptake inhibitors (SNRIs) are similar to SSRIs and include
venlafaxine (Effexor) and duloxetine (Cymbalta).
SSRIs and SNRIs tend to have fewer side effects than older
antidepressants, but they sometimes produce headaches,
nausea, jitters, or insomnia when people first start to take
them. Tese symptoms tend to fade with time. Some people
also experience sexual problems with SSRIs or SNRIs, which
may be helped by adjusting the dosage or switching to
another medication.
One popular antidepressant that works on dopamine is
bupropion (Wellbutrin). Bupropion tends to have similar
side effects as SSRIs and SNRIs, but it is less likely to cause
sexual side effects. However, it can increase a person’s risk for
seizures.
Tricyclics
Tricyclics are older antidepressants. Tricyclics are powerful,
but they are not used as much today because their potential
side effects are more serious. They may affect the heart in
people with heart conditions. Tey sometimes cause dizziness,
especially in older adults. Tey also may cause drowsiness,
dry mouth, and weight gain. These side effects can
usually be corrected by changing the dosage or switching to
another medication. However, tricyclics may be especially
dangerous if taken in overdose. Tricyclics include imipramine
and nortriptyline.
MAOIs
Monoamine oxidase inhibitors (MAOIs) are the oldest class
of antidepressant medications. Tey can be especially effective
in cases of “atypical” depression, such as when a person
experiences increased appetite and the need for more sleep
rather than decreased appetite and sleep. Tey also may help
with anxious feelings or panic and other specific symptoms.
However, people who take MAOIs must avoid certain foods
and beverages (including cheese and red wine) that contain
a substance called tyramine. Certain medications, including
some types of birth control pills, prescription pain relievers,
cold and allergy medications, and herbal supplements, also
should be avoided while taking an MAOI. Tese substances
can interact with MAOIs to cause dangerous increases in
blood pressure. Te development of a new MAOI skin patch
may help reduce these risks. If you are taking an MAOI, your
doctor should give you a complete list of foods, medicines, and
substances to avoid.
MAOIs can also react with SSRIs to produce a serious condition
called “serotonin syndrome,” which can cause confusion,
hallucinations, increased sweating, muscle stiffness, seizures,
changes in blood pressure or heart rhythm, and other potentially
life-threatening conditions. MAOIs should not be taken
with SSRIs.
Antidepressant Medications for Children and Adolescents:
Information for Parents and Caregivers
Depression is a serious disorder that can cause significant problems in mood, thinking, and behavior at home, in school, and with peers. It is estimated that major depressive disorder (MDD) affects about 5 percent of adolescents.
Research has shown that, as in adults, depression in children and adolescents is treatable. Certain antidepressant medications, called selective serotonin reuptake inhibitors (SSRIs), can be beneficial to children and adolescents with MDD. Certain types of psychological therapies also have been shown to be effective. However, our knowledge of antidepressant treatments in youth, though growing substantially, is limited compared to what we know about treating depression in adults.
Recently, there has been some concern that the use of antidepressant medications themselves may induce suicidal behavior in youths. Following a thorough and comprehensive review of all the available published and unpublished controlled clinical trials of antidepressants in children and adolescents, the U.S. Food and Drug Administration (FDA) issued a public warning in October 2004 about an increased risk of suicidal thoughts or behavior (suicidality) in children and adolescents treated with SSRI antidepressant medications. In 2006, an advisory committee to the FDA recommended that the agency extend the warning to include young adults up to age 25.
More recently, results of a comprehensive review of pediatric trials conducted between 1988 and 2006 suggested that the benefits of antidepressant medications likely outweigh their risks to children and adolescents with major depression and anxiety disorders. The study, partially funded by NIMH, was published in the April 18, 2007, issue of the Journal of the American Medical Association.
What Did the FDA Review Find?
In the FDA review, no completed suicides occurred among nearly 2,200 children treated with SSRI medications. However, about 4 percent of those taking SSRI medications experienced suicidal thinking or behavior, including actual suicide attempts—twice the rate of those taking placebo, or sugar pills.
In response, the FDA adopted a "black box" label warning indicating that antidepressants may increase the risk of suicidal thinking and behavior in some children and adolescents with MDD. A black-box warning is the most serious type of warning in prescription drug labeling.
The warning also notes that children and adolescents taking SSRI medications should be closely monitored for any worsening in depression, emergence of suicidal thinking or behavior, or unusual changes in behavior, such as sleeplessness, agitation, or withdrawal from normal social situations. Close monitoring is especially important during the first four weeks of treatment. SSRI medications usually have few side effects in children and adolescents, but for unknown reasons, they may trigger agitation and abnormal behavior in certain individuals.
What Do We Know About Antidepressant Medications?
The SSRIs (Selective Serotonin Reuptake Inhibitors) include:
• fluoxetine (Prozac)
• sertraline (Zoloft)
• paroxetine (Paxil)
• citalopram (Celexa)
• escitalopram (Lexapro)
• fluvoxamine (Luvox)
Another antidepressant medication, venlafaxine (Effexor), is not an SSRI but is closely related.
SSRI medications are considered an improvement over older antidepressant medications because they have fewer side effects and are less likely to be harmful if taken in an overdose, which is an issue for patients with depression already at risk for suicide. They have been shown to be safe and effective for adults.
However, use of SSRI medications among children and adolescents ages 10 to 19 has risen dramatically in the past several years. Fluoxetine (Prozac) is the only medication approved by the FDA for use in treating depression in children ages 8 and older. The other SSRI medications and the SSRI-related antidepressant venlafaxine have not been approved for treatment of depression in children or adolescents, but doctors still sometimes prescribe them to children on an "off-label" basis. In June 2003, however, the FDA recommended that paroxetine not be used in children and adolescents for treating MDD.
Fluoxetine can be helpful in treating childhood depression, and can lead to significant improvement of depression overall. However, it may increase the risk for suicidal behaviors in a small subset of adolescents. As with all medical decisions, doctors and families should weigh the risks and benefits of treatment for each individual patient.
What Should You Do for a Child With Depression?
A child or adolescent with MDD should be carefully and thoroughly evaluated by a doctor to determine if medication is appropriate. Psychotherapy often is tried as an initial treatment for mild depression. Psychotherapy may help to determine the severity and persistence of the depression and whether antidepressant medications may be warranted. Types of psychotherapies include "cognitive behavioral therapy," which helps people learn new ways of thinking and behaving, and "interpersonal therapy," which helps people understand and work through troubled personal relationships.
Those who are prescribed an SSRI medication should receive ongoing medical monitoring. Children already taking an SSRI medication should remain on the medication if it has been helpful, but should be carefully monitored by a doctor for side effects. Parents should promptly seek medical advice and evaluation if their child or adolescent experiences suicidal thinking or behavior, nervousness, agitation, irritability, mood instability, or sleeplessness that either emerges or worsens during treatment with SSRI medications.
Once started, treatment with these medications should not be abruptly stopped. Although they are not habit-forming or addictive, abruptly ending an antidepressant can cause withdrawal symptoms or lead to a relapse. Families should not discontinue treatment without consulting their doctor.
All treatments can be associated with side effects. Families and doctors should carefully weigh the risks and benefits, and maintain appropriate follow-up and monitoring to help control for the risks.
What Does Research Tell Us?
An individual's response to a medication cannot be predicted with certainty. It is extremely difficult to determine whether SSRI medications increase the risk for completed suicide, especially because depression itself increases the risk for suicide and because completed suicides, especially among children and adolescents, are rare. Most controlled trials are too small to detect for rare events such as suicide (thousands of participants are needed). In addition, controlled trials typically exclude patients considered at high risk for suicide.
One major clinical trial, the NIMH-funded Treatment for Adolescents with Depression Study (TADS), has indicated that a combination of medication and psychotherapy is the most effective treatment for adolescents with depression. The clinical trial of 439 adolescents ages 12 to 17 with MDD compared four treatment groups—one that received a combination of fluoxetine and CBT, one that received fluoxetine only, one that received CBT only, and one that received a placebo only. After the first 12 weeks, 71 percent responded to the combination treatment of fluoxetine and CBT, 61 percent responded to the fluoxetine only treatment, 43 percent responded to the CBT only treatment, and 35 percent responded to the placebo treatment.
At the beginning of the study, 29 percent of the TADS participants were having clinically significant suicidal thoughts. Although the rate of suicidal thinking decreased among all the treatment groups, those in the fluoxetine/CBT combination treatment group showed the greatest reduction in suicidal thinking.
Researchers are working to better understand the relationship between antidepressant medications and suicide. So far, results are mixed. One study, using national Medicaid files, found that among adults, the use of antidepressants does not seem to be related to suicide attempts or deaths. However, the analysis found that the use of antidepressant medications may be related to suicide attempts and deaths among children and adolescents.
Another study analyzed health plan records for 65,103 patients treated for depression. It found no significant increase among adults and young people in the risk for suicide after starting treatment with newer antidepressant medications.
A third study analyzed suicide data from the National Vital Statistics and commercial prescription data. It found that among children ages five to 14, suicide rates from 1996 to 1998 were actually lower in areas of the country with higher rates of SSRI antidepressant prescriptions. The relationship between the suicide rates and the SSRI use rates, however, is unclear.
New NIMH-funded research will help clarify the complex interplay between suicide and antidepressant medications. In addition, the NIMH-funded Treatment of Resistant Depression in Adolescents (TORDIA) study, will investigate how best to treat adolescents whose depression is resistant to the first SSRI medication they have tried. Finally, NIMH also is supporting the Treatment of Adolescent Suicide Attempters (TASA) study, which is investigating the treatment of adolescents who have attempted suicide. Treatments include antidepressant medications, CBT or both.
What Is Depression?
Depression (major depressive disorder) is a common and serious medical illness that negatively affects how you feel, the way you think and how you act. Fortunately, it is also treatable. Depression causes feelings of sadness and/or a loss of interest in activities once enjoyed. It can lead to a variety of emotional and physical problems and can decrease a person’s ability to function at work and at home.
Depression symptoms can vary from mild to severe and can include:
◦ Feeling sad or having a depressed mood
◦ Loss of interest or pleasure in activities once enjoyed
◦ Changes in appetite — weight loss or gain unrelated to dieting
◦ Trouble sleeping or sleeping too much
◦ Loss of energy or increased fatigue
◦ Increase in purposeless physical activity (e.g., hand-wringing or pacing) or slowed movements and speech (actions observable by others)
◦ Feeling worthless or guilty
◦ Difficulty thinking, concentrating or making decisions
◦ Thoughts of death or suicide
Symptoms must last at least two weeks for a diagnosis of depression.
Also, medical conditions (e.g., thyroid problems, a brain tumor or vitamin deficiency) can mimic symptoms of depression so it is important to rule out general medical causes.
Depression affects an estimated one in 15 adults (6.7%) in any given year. And one in six people (16.6%) will experience depression at some time in their life. Depression can strike at any time, but on average, first appears during the late teens to mid-20s. Women are more likely than men to experience depression. Some studies show that one-third of women will experience a major depressive episode in their lifetime.
Depression Is Different From Sadness or Grief/Bereavement
The death of a loved one, loss of a job or the ending of a relationship are difficult experiences for a person to endure. It is normal for feelings of sadness or grief to develop in response to such situations. Those experiencing loss often might describe themselves as being “depressed.”
But being sad is not the same as having depression. The grieving process is natural and unique to each individual and shares some of the same features of depression. Both grief and depression may involve intense sadness and withdrawal from usual activities. They are also different in important ways:
◦ In grief, painful feelings come in waves, often intermixed with positive memories of the deceased. In major depression, mood and/or interest (pleasure) are decreased for most of two weeks.
◦ In grief, self-esteem is usually maintained. In major depression, feelings of worthlessness and self-loathing are common.
◦ For some people, the death of a loved one can bring on major depression. Losing a job or being a victim of a physical assault or a major disaster can lead to depression for some people. When grief and depression co-exist, the grief is more severe and lasts longer than grief without depression. Despite some overlap between grief and depression, they are different. Distinguishing between them can help people get the help, support or treatment they need.
Risk Factors for Depression
Depression can affect anyone—even a person who appears to live in relatively ideal circumstances.
Several factors can play a role in depression:
◦ Biochemistry: Differences in certain chemicals in the brain may contribute to symptoms of depression.
◦ Genetics: Depression can run in families. For example, if one identical twin has depression, the other has a 70 percent chance of having the illness sometime in life.
◦ Personality: People with low self-esteem, who are easily overwhelmed by stress, or who are generally pessimistic appear to be more likely to experience depression.
◦ Environmental factors: Continuous exposure to violence, neglect, abuse or poverty may make some people more vulnerable to depression.
How Is Depression Treated?
Depression is among the most treatable of mental disorders. Between 80 percent and 90 percent of people with depression eventually respond well to treatment. Almost all patients gain some relief from their symptoms.
Before a diagnosis or treatment, a health professional should conduct a thorough diagnostic evaluation, including an interview and possibly a physical examination. In some cases, a blood test might be done to make sure the depression is not due to a medical condition like a thyroid problem. The evaluation is to identify specific symptoms, medical and family history, cultural factors and environmental factors to arrive at a diagnosis and plan a course of action.
Medication: Brain chemistry may contribute to an individual’s depression and may factor into their treatment. For this reason, antidepressants might be prescribed to help modify one’s brain chemistry. These medications are not sedatives, “uppers” or tranquilizers. They are not habit-forming. Generally antidepressant medications have no stimulating effect on people not experiencing depression.
Antidepressants may produce some improvement within the first week or two of use. Full benefits may not be seen for two to three months. If a patient feels little or no improvement after several weeks, his or her psychiatrist can alter the dose of the medication or add or substitute another antidepressant. In some situations other psychotropic medications may be helpful. It is important to let your doctor know if a medication does not work or if you experience side effects.
Psychiatrists usually recommend that patients continue to take medication for six or more months after symptoms have improved. Longer-term maintenance treatment may be suggested to decrease the risk of future episodes for certain people at high risk.
Psychotherapy: Psychotherapy, or “talk therapy,” is sometimes used alone for treatment of mild depression; for moderate to severe depression, psychotherapy is often used in along with antidepressant medications. Cognitive behavioral therapy (CBT) has been found to be effective in treating depression. CBT is a form of therapy focused on the present and problem solving. CBT helps a person to recognize distorted thinking and then change behaviors and thinking.
Psychotherapy may involve only the individual, but it can include others. For example, family or couples therapy can help address issues within these close relationships. Group therapy involves people with similar illnesses.
Depending on the severity of the depression, treatment can take a few weeks or much longer. In many cases, significant improvement can be made in 10 to 15 sessions.
Electroconvulsive Therapy (ECT) is a medical treatment most commonly used for patients with severe major depression or bipolar disorder who have not responded to other treatments. It involves a brief electrical stimulation of the brain while the patient is under anesthesia. A patient typically receives ECT two to three times a week for a total of six to 12 treatments. ECT has been used since the 1940s, and many years of research have led to major improvements. It is usually managed by a team of trained medical professionals including a psychiatrist, an anesthesiologist and a nurse or physician assistant.
Self-help and Coping
There are a number of things people can do to help reduce the symptoms of depression. For many people, regular exercise helps create positive feeling and improve mood. Getting enough quality sleep on a regular basis, eating a healthy diet and avoiding alcohol (a depressant) can also help reduce symptoms of depression.
Depression is a real illness and help is available. With proper diagnosis and treatment, the vast majority of people with depression will overcome it. If you are experiencing symptoms of depression, a first step is to see your family physician or psychiatrist. Talk about your concerns and request a thorough evaluation. This is a start to addressing mental health needs.
Related Conditions
◦ Peripartum depression (previously postpartum depression)
◦ Seasonal depression (Also called seasonal affective disorder)
◦ Persistent depressive disorder (previously dysthymia)
◦ Premenstrual dysphoric disorder
◦ Disruptive mood dysregulation disorder
◦ Bipolar disorders
PRACTICE GUIDELINE FOR THE Treatment of Patients With Major Depressive Disorder
Pharmacotherapy
• The effectiveness of antidepressant medications is generally
comparable between and within classes of medications, including
selective serotonin reuptake inhibitors (SSRIs), serotonin
norepinephrine reuptake inhibitors (SNRIs), bupropion,
tricyclic antidepressants (TCAs), and monoamine oxidase inhibitors
(MAOIs). Therefore, choose a medication largely based
on the following:
• Patient preference
• Nature of prior response to medication
• Safety, tolerability, and anticipated side effects
• Co-occurring psychiatric or general medical conditions
• Pharmacological properties of the medication (e.g., halflife,
actions on cytochrome P450 enzymes, other drug
interactions; consult the full guideline or a current drug
database)
• Cost
• For most patients, a SSRI, a SNRI, mirtazapine, or bupropion
is optimal.
• In general, the use of MAOIs should be restricted to patients
who do not respond to other treatments.
• Table 2 provides the starting and usual doses of medications
that have been shown to be effective for treating major depressive
disorder.
• If side effects occur, lowering the dose or changing to a different
antidepressant should be considered. If these approaches
are not effective, other strategies can be considered, as shown
in Table 3.
TABLE 2. DOSING OF MEDICATIONS SHOWN TO BE EFFECTIVE IN TREATING MAJOR DEPRESSIVE DISORDERa
Seasonal Affective Disorder (SAD)
What is Seasonal Affective Disorder?
Seasonal affective disorder* is a form of depression also known as SAD, seasonal depression or winter depression. People with SAD experience mood changes and symptoms similar to depression. The symptoms usually occur during the fall and winter months when there is less sunlight and usually improve with the arrival of spring. The most difficult months for people with SAD in the U.S. tend to be January and February. While it is much less common, some people experience SAD in the summer.
SAD is more than just “winter blues.” The symptoms can be distressing and overwhelming and can interfere with daily functioning. However, it can be treated. About 5 percent of adults in the U.S. experience SAD and it typically lasts about 40 percent of the year. It is more common among women than men.
SAD has been linked to a biochemical imbalance in the brain prompted by shorter daylight hours and less sunlight in winter. As seasons change, people experience a shift in their biological internal clock or circadian rhythm that can cause them to be out of step with their daily schedule. SAD is more common in people living far from the equator where there are fewer daylight hours in the winter.
Symptoms and Diagnosis
Common symptoms of SAD include fatigue, even with too much sleep, and weight gain associated with overeating and carbohydrate cravings. SAD symptoms can vary from mild to severe and can include many symptoms similar to major depression, such as:
◦ Feeling of sadness or depressed mood
◦ Marked loss of interest or pleasure in activities once enjoyed
◦ Changes in appetite; usually eating more, craving carbohydrates
◦ Change in sleep; usually sleeping too much
◦ Loss of energy or increased fatigue despite increased sleep hours
◦ Increase in restless activity (e.g., hand-wringing or pacing) or slowed movements and speech
◦ Feeling worthless or guilty
◦ Trouble concentrating or making decisions
◦ Thoughts of death or suicide or attempts at suicide
SAD may begin at any age, but it typically starts when a person is between ages 18 and 30.
Treatment
SAD can be effectively treated in a number of ways, including light therapy, antidepressant medications, talk therapy or some combination of these. While symptoms will generally improve on their own with the change of season, symptoms can improve more quickly with treatment.
Light therapy involves sitting in front of a light therapy box that emits very bright light (and filters out harmful ultraviolet (UV) rays). It usually requires 20 minutes or more a day, typically first thing in the morning, during the winter. Most people see some improvements from light therapy within one or two weeks of beginning treatment. To maintain the benefits and prevent relapse, treatment is usually continued through the winter. Because of the anticipated return of symptoms in late fall, some people may begin light therapy in early fall to prevent symptoms.
Talk therapy, particularly cognitive behavior therapy, can effectively treat SAD. Selective serotonin reuptake inhibitors (SSRIs) are the type of antidepressant most commonly used to treat SAD.
For some people, increased exposure to sunlight can help improve symptoms of SAD. For example, spending time outside or arranging your home or office so that you are exposed to a window during the day. (However, exposure to UV light from the sun can increase your risk of skin cancer. Talk with your doctor about risks and benefits.) Taking care of your general health and wellness can also help—regular exercise, healthy eating, getting enough sleep, and staying active and connected (such as volunteering, participating in group activities and getting together with friends and family) can help.
If you feel you have symptoms of SAD, seek the help of a trained medical professional. Just as with other forms of depression, it is important to make sure there is no other medical condition causing symptoms. SAD can be misdiagnosed as hypothyroidism, hypoglycemia, infectious mononucleosis, and other viral infections, so proper evaluation is key. A mental health professional can diagnose the condition and discuss therapy options. With the right treatment, SAD can be a manageable condition.
If you feel the depression is severe or if you are experiencing suicidal thoughts, consult a doctor immediately or seek help at the closest emergency room. National Suicide Prevention Lifeline – 800-273-TALK (8255).
*In the Diagnostic Manual of Mental Disorders (DSM-5), this disorder is identified as a type of depression – Major Depressive Disorder with Seasonal Pattern.
ANTIDEPRESSANTS AND THE RISK OF SUICIDAL BEHAVIOR
CONTENT:
◦ Introduction
◦ Food and Drug Administration Advisory Statement
◦ Effectiveness of Selective Serotonin Reuptake Inhibitors (SSRIs) and the Risk of Suicidality
◦ Limitations of the Research on Suicidality and Antidepressants
◦ Conclusion
Introduction
Research indicates that as many as 11 percent of adolescents will experience depression (National
Institute of Mental Health (NIMH), n.d.a). Furthermore, according to NIMH, the leading causes of
disability in persons aged 15 to 44 years old are depressive disorders. Because depressive disorders (i.e.
depression) substantially increase the risk of suicide, much focus has been placed on measuring the
effectiveness of treatments for depression. This is particularly true for adolescents because depression in
that age group is a strong indicator of suicidal behavior (Treatment for Adolescents with Depression
Study (TADS), 2004; Miller, Rathus & Linehan, 2007). Given the serious nature of depression in
adolescents, it is imperative that the most effective treatment be made available while minimizing any
associated risks (Lock, Walker, Rickert & Katzman, 2005).
Different treatments have been shown to be effective for children and adolescents diagnosed with
depression. Certain antidepressant medications, including selective serotonin reuptake inhibitors (SSRIs),
have been shown to be effective in as many as 7.5 percent of American children who are taking
antidepressants and other behavior-modifying medications (NIMH, n.d.b; Heasley, 2014). However,
research has also revealed a possible relationship between suicidal thoughts or actions and the use of
SSRIs in children and adolescents with depression. This section will review the current literature on the
benefits and risks associated with antidepressant use in children and adolescents with depression.
Additional information about effective treatments for youth with depression is located in the “Depressive
Disorders” section of the Collection.
Food and Drug Administration Advisory Statement
............... ...............
............... ...............
The most recent update to the FDA’s (2007) warning is outlined in Figure 1.
Figure 1: Key Points of FDA Black-Box Warning Label For Suicidality and Anti-Depressant Drugs
• Antidepressants increase the risk of suicidal thinking and behavior in
children and adolescents with MDD and other psychiatric disorders.
• Anyone considering the use of an antidepressant in a child or adolescent
for any clinical use must balance the risk of increased suicidality with the
clinical need.
• Taper dosage to prevent risks of discontinuation syndrome if stopping
SSRI treatment.
• Patients who are started on antidepressant therapy should be observed
closely for agitation, irritability, clinical worsening, suicidality, or
unusual changes in behavior.
• Families and caregivers should be advised to closely observe the patient
and to communicate with the prescriber.
• A statement regarding whether the particular drug is approved for any
pediatric indication(s) and, if so, which one(s), should be present.
Sources: FDA, 2007; Wolf, 2005.
Effectiveness of Selective Serotonin Reuptake Inhibitors (SSRIs) and the Risk of Suicidality
In evaluating the risk-benefit ratio of using antidepressants, particularly SSRIs, for children and
adolescents diagnosed with depression, it is important to have an understanding of the evidence
supporting the use of these medicines to counteract suicidal behavior and the risk for suicide in untreated
depression. Much of what is known about the benefits of antidepressants in treating youth with depression
comes from the Treatment for Adolescents with Depression Study (TADS, 2004). ..............
.
TADS compared four different treatment conditions for adolescents with depression: cognitive behavioral
therapy (CBT), SSRI therapy (fluoxetine), combined CBT and SSRI therapy, and a placebo.
TADS’s data indicated that there was an increase in harm-related events among adolescents who
received fluoxetine as part of treatment. Specifically, adolescents treated with fluoxetine alone were twice
as likely to experience a suicidal event compared with those treated with combination therapy or just CBT.
The study team also concluded that, after accounting for benefit and risk, the combination of fluoxetine
and CBT was more effective than either treatment alone. Additionally, the SSRI treatment alone was
shown to be more effective than the placebo (TADS, 2004). In fact, 61 percent of the youth treated with
fluoxetine experienced a reduction in their depressive symptoms, compared to 35 percent for the placebo
(Lock, Walker, Rickert & Katzman, 2005).
The primary conclusion of TADS was that fluoxetine treatment for depression in youth is effective, but
accompanied with some risks, whereas combining CBT with fluoxetine can improve outcomes and reduce
the risks associated with fluoxetine (TADS). Overall, fluoxetine has demonstrated the largest difference
between active drug and placebo (American Academy of Child & Adolescent Psychiatry [AACAP],
2007). It is unclear why other SSRIs have not consistently demonstrated effectiveness over placebo, but
possibilities include limited effectiveness, poor study design, too-low doses, and insufficient duration of
treatment (AACAP).
A recent study conducted a meta-analysis of available data and concluded that out of 14 available
antidepressants, the only effective antidepressant for children and adolescents with major depression is
fluoxetine (Cipriani et al., 2016). This study found that fluoxetine was the only medication that had
reliable research to back its effectiveness when compared with a placebo. However, it is important to note
that children and adolescents taking antidepressant drugs should be closely monitored regardless of the
treatment chosen, particularly at the beginning of treatment.
Researchers have also looked at the trends in suicide since SSRIs became more commonly used. Olfson,
Shaffer, Marcus, and Greenberg (2003) examined the trend in the number of suicides occurring from
1990 to 2000 compared to the number of youth prescribed antidepressants during that period. This study
found an inverse relationship between youth suicide and use of antidepressants, and noted that the
increased rate of antidepressant use in children and adolescents from 1990 to 2000 was associated with an
overall decrease in suicide rates (Olfson et al.). Furthermore, analysis indicated that SSRI use was
associated with an even more notable decrease in the suicide rate in high-risk populations; older
adolescents and males; and underserved populations, minorities, and low-income youth (Olfson et al.).
Another study comparing the use of CBT, sertraline (an SSRI), CBT plus sertraline, and a placebo in the
treatment of youth with anxiety disorders found that, when compared to the placebo, sertraline was not
associated with increased suicidality (Walkup et al., 2008). There were no suicide attempts and there were
no significant differences in the rate of suicidal ideation between any of the groups (Walkup et al.). This
study, however, focused on anxious, rather than depressed youth. Thus, the study does not directly
address the risk associated with employing SSRIs in treating depressed youth.
A recent study led by Harvard Medical School (Lu et al., 2014) investigated whether the FDA black-box
warnings were linked to changes in antidepressant use, suicide attempts, and completed suicides among
young people. The study found that FDA warnings and associated media coverage were associated with
decreases in antidepressant use and small increases in suicide attempts. Health care organizations that
provided care to 10 million people in 12 states participated in the study. The study noted that, after the
FDA’s warnings, use of commonly prescribed antidepressants fell by 30 percent in adolescents and 25
percent in young adults. The researcher also found that suicide attempts rose in adolescents and young
adults. However, no changes were detected in completed suicides. The researchers cautioned that the
study did have limitations because it only measured suicide attempts that received medical attention. Data
sources also lacked information on patient outcomes and were limited to the insured population. The
researchers concluded that reductions in antidepressant use, generated by concern over suicidal thoughts,
might have left a portion of depressed young people without appropriate treatment, which may have
caused a small increase in suicide attempts.
A comprehensive analysis of health care data of U.S. residents with depression who initiated
antidepressant therapy with SSRIs found a connection between dosage and age. The study found that
younger patients who began treatment with higher-than-recommended doses of antidepressants were
more than twice as likely to try to harm themselves as those who were initially treated with the same
drugs at lower, recommended doses (Miller, Swanson, Azrael, Pate, & Stürmer, 2014). The risk of suicide
attempts seemed to be highest in the first 90 days on the medications (Miller et al.). This analysis did not
detect an increase in suicide risk in youth and adolescents treated with recommended drug dosages.
Limitations of the Research on Suicidality and Antidepressants
When making decisions about the risks associated with antidepressants, particularly SSRIs, it is important
to understand the limitations of the research. Suicidality can be very difficult to measure as these events
are rare, and the statistical method used to evaluate the risk associated with treating children and
adolescents with antidepressants can only be used in studies where a minimum of one adverse event has
taken place (AACAP, 2007). Conversely, a study that fails to detect a significant increase in suicidal risk
associated with antidepressant medication does not necessarily indicate that there is not a risk (Walkup et
al., 2008).
Hammad, Laughren and Racoosin outlined some of the major limitations of the meta-analysis of
suicidality in the antidepressant treatment trials (2006). These limitations are:
• Subsequent analysis using the same data increases the uncertainty of the results.
• Analysis is based on short term (4 to 16 weeks) outcomes, making any conclusions about the
long-term consequences of antidepressants in youth impossible, although SSRI-related suicidality
would be expected to occur within this time frame.
• Measuring suicidal ideation and behavior is inherently difficult due to the distressing nature of the
topic.
A separate study noted other potential research limitations, such as the inability to adjust for the severity
of the disorder or for antidepressant adherence (Miller et al., 2014). Moreover, it is difficult to know
whether the increase in suicidal ideation and behavior represents a true increase or simply a change in the
rate of report (Hammad, Laughren & Racoosin). Additionally, all of the trials used by the FDA in making
the decision about the black-box warning excluded youth with severe suicidality (Guirgus-Blake, Wright
& Rich, 2008). However, the inverse relationship between use of SSRIs and the rate of suicidal behavior
is also compelling. Thus, categorical conclusions about the effects of antidepressants on suicidality are
difficult to formulate. Knowing the effects of antidepressants on youth with severe suicidality is critical,
but more research is required for clearer direction.
Conclusion
In summary, the evidence suggests that antidepressants are associated with an increase in suicidal
behavior among youth and young adults. There is, however, evidence to suggest that the benefits
associated with treating moderately to severely depressed youth with antidepressants outweighs the risks
(Hammad, Laughren & Racoosin, 2006; AACAP, 2007).
The results of research conducted by Olfson et al. (2003) suggest that the use of antidepressants has
significantly decreased the rate of suicides, yet drug treatment trials indicate that antidepressant use
increases the rate of suicidal ideation and behavior among adolescents (Hammad et al., 2006; TADS,
2004). There is also evidence that SSRIs are more effective than placebo medication in treating
adolescents with depressive disorders and that the risks associated with SSRIs can be reduced when youth
are concurrently receiving CBT (Sharp & Hellings, 2006; TADS). This is a significant finding in the
discussion of the effects of antidepressants on suicide since depressive disorders are a significant
predictor of suicidal ideation, suicide attempts, and completed suicide (Gould, Shaffer & Greenberg,
2003). Another significant finding is that the period of greatest risk for increased suicidality appears to be
in the early stages of SSRI treatment (Lock et al., 2005).
A position paper of the Society for Adolescent Medicine concluded that, after balancing the increased risk
of suicidality among adolescents treated with SSRIs with their benefits, the evidence supported the use of
SSRIs for adolescents with MDD (Lock et al., 2005). The American Medical Association (AMA) has
asserted that its review of various studies supports the view that antidepressants reduce suicidal behavior
and completed suicide attempts overall (2005). The organization does acknowledge, however, that the
risk of suicidal behavior appears to be highest during the initial course of drug therapy. The AMA’s
position is that antidepressants should continue to be available with their use guided by sensible clinical
judgment (AMA). The AACAP concluded that, with close supervision, the risk-to-benefit ratio supports
using SSRIs in the treatment of child and adolescent depression (2007). The Society for Adolescent
Medicine, AMA, AACAP, and American Psychological Association (APA) support the use of fluoxetine,
the only medication approved by the FDA for the treatment of youth with depression, but recommend
close monitoring by both parents and clinicians (FDA, 2004; Lock et al., 2005; AMA, 2005; AACAP,
2007; APA, 2006).